Premium-Priced, Branded Generic Pharmaceuticals in Emerging Economies

IF 0.4 Q4 ETHICS BUSINESS & PROFESSIONAL ETHICS JOURNAL Pub Date : 2020-09-24 DOI:10.5840/bpej202091099
Thomas A. Hemphill, Scott D. Johnson
{"title":"Premium-Priced, Branded Generic Pharmaceuticals in Emerging Economies","authors":"Thomas A. Hemphill, Scott D. Johnson","doi":"10.5840/bpej202091099","DOIUrl":null,"url":null,"abstract":"Is it socially responsible to price at a premium, company branded generic pharmaceuticals in emerging economies? Building toward an answer to this question, the study first describes the role of the branded generic sector in the economic success of the global pharmaceutical industry. Second, the concept of “shared value,” i.e., the link between competitive advantage (and its theoretical antecedents found in corporate reputation and signaling theory) and corporate social responsibility (CSR), is introduced and applied to the global pharmaceutical industry’s position on marketing generic pharmaceuticals. Third, an empirical evaluation ascertains whether there is sufficient shared value for this company branded generics pricing strategy to be considered “socially responsible.” Fourth, after concluding there is sufficient shared value, a discussion section offers a public/private (corporate and industry self-regulation) framework that will help ensure that safe and effective pharmaceuticals are sold to consumers in developing economies. Lastly, a summary and conclusion section completes the article.","PeriodicalId":53983,"journal":{"name":"BUSINESS & PROFESSIONAL ETHICS JOURNAL","volume":null,"pages":null},"PeriodicalIF":0.4000,"publicationDate":"2020-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BUSINESS & PROFESSIONAL ETHICS JOURNAL","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5840/bpej202091099","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ETHICS","Score":null,"Total":0}
引用次数: 0

Abstract

Is it socially responsible to price at a premium, company branded generic pharmaceuticals in emerging economies? Building toward an answer to this question, the study first describes the role of the branded generic sector in the economic success of the global pharmaceutical industry. Second, the concept of “shared value,” i.e., the link between competitive advantage (and its theoretical antecedents found in corporate reputation and signaling theory) and corporate social responsibility (CSR), is introduced and applied to the global pharmaceutical industry’s position on marketing generic pharmaceuticals. Third, an empirical evaluation ascertains whether there is sufficient shared value for this company branded generics pricing strategy to be considered “socially responsible.” Fourth, after concluding there is sufficient shared value, a discussion section offers a public/private (corporate and industry self-regulation) framework that will help ensure that safe and effective pharmaceuticals are sold to consumers in developing economies. Lastly, a summary and conclusion section completes the article.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
新兴经济体的高价、品牌仿制药
在新兴经济体,以溢价定价、公司品牌的仿制药是否对社会负责?为了回答这个问题,该研究首先描述了品牌仿制药行业在全球制药行业经济成功中的作用。其次,引入了“共享价值”的概念,即竞争优势(及其在企业声誉和信号理论中的理论前因)和企业社会责任(CSR)之间的联系,并将其应用于全球制药行业在仿制药营销方面的地位。第三,实证评估确定该公司品牌仿制药定价策略是否有足够的共享价值,以被视为“社会责任”。第四,在得出有足够共享价值的结论后,讨论部分提供了一个公共/私营(企业和行业自律)框架,将有助于确保向发展中经济体的消费者销售安全有效的药品。最后,总结和结论部分完成了文章。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
1.00
自引率
0.00%
发文量
10
期刊最新文献
Autonomy and Subordination Applying Kant’s Ethics to Video Game Business Models A Necessary Ethics Definition for Conflicts of Interest Examining Job Satisfaction and Organizational Commitment as Motivators of Unethical Pro-Organizational Behavior Intolerable Ideologies and the Obligation to Discriminate
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1